PRIMARY STUDY

Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson's disease.

Key Findings:  These results demonstrate an effect of fatty acid amide hydrolase inhibition on the motor symptoms of Parkinson's disease in two distinct experimental models that is mediated by cannabinoid receptors.

Type of Study:  Animal Study

Study Result:  Positive


Cannabinoids Studied:  Fatty Acid Amide Hydrolase (FAAH), Other Related Compounds

Phytocannabinoid Source:  Not Applicable

Form of Administration:  Not Applicable

Receptors Studied:  CB1, CB2

Ligands Studied:  Dopamine


Study Location(s):  Spain, United States

Year of Pub:  2016


Link to study